3beta-Hydroxy-DELTA5-cholenic Acid>97.0%(T)1g

1,2-Ethanediamine, N1-methyl-N1-[[4-[4-(1-methylethoxy)phenyl]-1H-pyrrol-3-yl]methyl]-, 98%, 250mg

2,5-Dibromo-4-fluoroaniline, 95.0%, 1g

Quinuclidine hydrochloride, 95+%, 1g

3-[1-(methylamino)ethyl]phenol hydrochloride, 97%, 50mg

Volumetric flasks class A opaque, 10 ml, 10/19, 2 Piece(s)

2-Bromo-3-chloro-4-nitropyridine, 95+%, 100mg

Phenyl trifluoroacetate, 98.0%, 100g

[S(R)]-N-[(S)-[4-(1,1-Dimethylethyl)phenyl][5-(diphenylphosphino)-9,9-dimethyl-9H-xanthen-4-yl]methyl]-2-methyl-2-propanesulfinamide, 95%, 250mg

1-Hexyl-3-methylimidazolium Bis(trifluoromethanesulfonyl)imide>98.0%(HPLC)(T)25g

tert-butyl 2-(3-trifluoromethylphenyl)-5-(pyrrolidin-1-ylcarbonyl)-5,7-dihydro-6H-pyrrolo[3,4-d]pyrimidine-6-carboxylate, 50mg

ethyl 3-(dibutylamino)propanoate, 95.0%, 10g

4-METHYL-5-NITRO-1H-INDAZOLE, 95%, 100mg